Fundamental analysis · SEC EDGAR · TTM through 31/12/2025
CAH · NYSE · Healthcare
Fundamental quality
63
out of 100
Source: SEC EDGAR · TTM through 31/12/2025
The score combines growth, profitability and financial strength. Here its growth weighs in its favor, while its profitability drags it down the most.
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2021 | $162,467M | $611M | $2,029M | -$3,407M |
| 2022 | $181,326M | -$938M | $2,788M | -$4,717M |
| 2023 | $204,979M | $330M | $2,363M | -$4,076M |
| 2024 | $226,827M | $852M | $3,251M | -$5,133M |
| 2025 | $222,578M | $1,561M | $1,850M | -$3,874M |
Between 2021 and 2025, revenue went from $162,467M to $222,578M (+37%) and net income went from $611M to $1,561M (+155%).
Annual figures in U.S. dollars per SEC filings. Net debt is total debt minus cash.
Is Cardinal Health Inc a profitable company?
Cardinal Health Inc is profitable, with a net margin of 0.7%, though a thin one.
Does Cardinal Health Inc have a lot of debt?
Not particularly. Its net debt is 0.02 times its EBITDA, a low level.
Is Cardinal Health Inc growing?
Its revenue has grown 8.9% annualized in recent years and its earnings per share 83.2%.
Does Cardinal Health Inc generate cash?
Yes. It converts about 2.2% of its revenue into free cash flow.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
Is Cardinal Health Inc cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Brokers you can use to invest in U.S. and European stocks.
The serious investor's standard →
Popular in the U.S. →
Other analyses
NVIDIA (NVDA) · Microsoft (MSFT) · Apple (AAPL) · Alphabet (Google) (GOOGL) · Amazon (AMZN) · Meta Platforms (META) · see more →